Publications by authors named "Noelia Jorge"
Objectives: To evaluate if the detection of N antigen of SARS-CoV-2 in plasma by a rapid lateral flow test predicts 90-day mortality in COVID-19 patients hospitalized at the wards.
Methods: The presence of N-antigenemia was evaluated in the first 36 hours after hospitalization in 600 unvaccinated COVID-19 patients, by using the Panbio COVID-19 Ag Rapid Test Device from Abbott (Abbott Laboratories Inc., Chicago, IL, USA).
Article Synopsis
- Low levels of anti-SARS-CoV-2 S antibodies in critically ill COVID-19 patients are linked to higher mortality rates and suggest that these antibodies play a protective role.
- The study involved 92 ICU patients and showed that absence of these antibodies coincided with increased viral RNA in plasma and higher rates of N-antigenaemia.
- The findings indicate that monitoring antibody levels could be crucial for understanding patient outcomes and managing severe COVID-19 cases effectively.
We aimed to examine the circulating microRNA (miRNA) profile of hospitalized COVID-19 patients and evaluate its potential as a source of biomarkers for the management of the disease. This was an observational and multicenter study that included 84 patients with a positive nasopharyngeal swab Polymerase chain reaction (PCR) test for SARS-CoV-2 recruited during the first pandemic wave in Spain (March-June 2020). Patients were stratified according to disease severity: hospitalized patients admitted to the clinical wards without requiring critical care and patients admitted to the intensive care unit (ICU).
View Article and Find Full Text PDFBackground: COVID-19 can course with respiratory and extrapulmonary disease. SARS-CoV-2 RNA is detected in respiratory samples but also in blood, stool and urine. Severe COVID-19 is characterized by a dysregulated host response to this virus.
View Article and Find Full Text PDF